A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...

Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...

First Phase III results from the clinical development program QUANTI on investigational MRI contrast agent gadoquatrane presented as late-breaking data during a scientific session at the 2025 European ...

Contrast agents could provide an efficient means for physicians to detect infections through imaging, rather than unnecessarily prescribing antibiotics, according to a Technology Review report. Two ...

ORLANDO, FL — In the AVERT trial of close to 600 patients who underwent coronary angiography and were at high risk of contrast-induced acute kidney injury (AKI), the studied device successfully ...

The FDA has approved Bracco’s gadopiclenol-based contrast agent, Vueway, for IV MRI imaging in neonates and infants. Vueway is a macrocyclic gadolinium-based contrast agent that delivers effective ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--GE Healthcare’s innovative shatterproof polymer +PLUSPAK Pharmacy Bulk Package has been approved by the US FDA for use with its macrocyclic gadolinium-based MRI ...

CORVALLIS, Ore. (KTVZ) -– Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents ...

BR55 was safe and highly accurate (>95%) at marking VEGFR2 expression in patients with breast, ovarian and thyroid cancer, as well as Crohn disease. The Food and Drug Administration (FDA) has granted ...

A new study has found why MRI scans may leave harmful metals behind in a person's body. The University of New Mexico (UNM) study explored health risks caused by toxic rare earth metal gadolinium, ...

A comprehensive study by the CritMET research group, led by Prof. Michael Bau, a geochemist at Constructor University in Bremen, provides evidence of widespread contamination of the North Sea and the ...